Sign in
CompletedNo phase

Standardized Instruments to Provide Diagnostic and Prognostic Information in Mild Traumatic Brain Injury (mTBI)

Key facts

Who runs it
Carey Balaban
Where
Miami, Pittsburgh, and San Diego, United StatesSee the 3 sites
Trial code
Status
Completed
People taking part
161 people enrolled
Started
30 Sept 2020
Ended
31 Mar 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Diagnostic test
Record updated
22 January 2026

Who can take part

Age
18 years to 50 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • For the mTBI group, participants must present to a recruitment site within 10 days of injury with a diagnosed concussion that meets all of the following criteria:
  • clear mechanism of injury (i.e., direct or indirect impact to head),
  • Glasgow Coma Scale= 13-15, 3) observed or reported signs (e.g., loss of consciousness, amnesia, or confusion) or symptoms (e.g., headache, dizziness, nausea), and
  • neurosensory symptoms; For Control group, participants will have minor, non-surgical injuries (e.g., sprains, strains) not requiring hospital admission and no history of mTBI will be recruited from the same study sites

Who cannot take part

  • mTBI history; mTBI Group - history of mTBI within the last 6 months or experiencing head injury symptoms immediately prior to the current head injury or history of 3 or more mTBIs; Controls - No history of mTBI within the last 12 months and no presence of any mTBI-related symptoms at time of enrollment
  • Prior disorders of hearing and balance including:; Meniere's disease; Multiple sclerosis; Vestibular neuritis; Vestibular schwannoma; Sudden sensorineural hearing loss
  • History of moderate to severe TBI characterized by any of the following:; Penetrating head trauma; GCS< 13 at the time of injury; Associated with LOC > 30 minutes or amnesia >24 hours; Associated with subdural or epidural hemorrhage
  • History of diagnosed psychiatric disorder (e.g., schizophrenia)
  • Documented neurological disorders (e.g., Epilepsy, stroke, dementia)
  • History of tumor of the brain or central nervous system
  • Presence of severe aphasia
  • Pregnancy (females will be asked if they are pregnant)

Where in United States

  • University of MiamiMiami, United States
  • University of PittsburghPittsburgh, United States
  • Naval Medical Center -San DiegoSan Diego, United States

About the trial

What the trial wants to find out

This study will establish the capability of a suite of conventional tests and the Neurolign Dx_100 I-PAS goggle system to reliably and objectively detect mTBI in an acute setting when comparing individuals with mTBI to controls with minor injuries in a similarly stressful environment.

The 2 groups in the trial

  • Mild Traumatic Brain Injury ParticipantsTreatment being tested

    Males and females from 18-50 years of age who present to a recruitment site within 10 days of injury with a diagnosed concussion that meets all of the following criteria: 1) clear mechanism of injury (i.e., direct or indirect impact to head), 2) Glasgow Coma Scale= 13-15, 3) observed or reported signs (e.g., loss of consciousness, amnesia, or confusion) or symptoms (e.g., headache, dizziness, nausea), and 3) neurosensory symptoms.

    Treatment: Diagnostic test

  • Control ParticipantsExisting treatment, for comparison

    Age- and sex-matched control subjects with minor, non-surgical injuries (e.g., sprains, strains) not requiring hospital admission and no history of mild traumatic brain injury will be recruited from the same study sites.

    Treatment: Diagnostic test

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
22 January 2026